Acorai raises $4.5m to advance heart monitoring device trial Source Cluster: Medical Device Network Source Node: 3078542Time Stamp: Jan 22, 2024
American Nurses Association Publicly Supports Rescheduling Source Cluster: The Fresh Toast Source Node: 3074657Time Stamp: Jan 19, 2024
American Nurses Association Publicly Supports Rescheduling Source Cluster: The Fresh Toast Source Node: 3074658Time Stamp: Jan 19, 2024
Leading Cannabis Justice Advocates Plan 420 Unity Day of Action on 4/18 in Source Cluster: MGRetailer Source Node: 3074636Time Stamp: Jan 19, 2024
Leading Cannabis Justice Advocates Plan 420 Unity Day of Action on 4/18 in Source Cluster: MGRetailer Source Node: 3074637Time Stamp: Jan 19, 2024
Summa Therapeutics performs first injectable angioplasty in PAD patients Source Cluster: Medical Device Network Source Node: 3071321Time Stamp: Jan 19, 2024
OrganOx and eGenesis advance in porcine liver replacement trial Source Cluster: Medical Device Network Source Node: 3071323Time Stamp: Jan 19, 2024
Nectero starts clinical trial for endovascular aneurysm stabilisation system Source Cluster: Medical Device Network Source Node: 3075256Time Stamp: Jan 19, 2024
FDA approves expanded MRI labelling for Abbott’s neurostimulator Source Cluster: Medical Device Network Source Node: 3075258Time Stamp: Jan 19, 2024
FDA approves AI-powered skin cancer-screening device Source Cluster: The Register Source Node: 3070421Time Stamp: Jan 18, 2024
Onward Medical kicks off feasibility study for ARC-IM neurostimulator Source Cluster: Medical Device Network Source Node: 3068525Time Stamp: Jan 18, 2024
MDCG Guidance on Clinical Investigation: Timelines | MDCG Source Cluster: Reg Desk Source Node: 3068527Time Stamp: Jan 18, 2024
FDA Draft Guidance on Third Party Review Program: Documentation and Reporting | United States Source Cluster: Reg Desk Source Node: 3068529Time Stamp: Jan 18, 2024
SAHPRA Guidelines on Establishment Licensing: General Questions | SAHPRA Source Cluster: Reg Desk Source Node: 3071325Time Stamp: Jan 18, 2024
SFDA Guidance on Product Classification: Specific Categories | SFDA Source Cluster: Reg Desk Source Node: 3071327Time Stamp: Jan 18, 2024
FDA Draft Guidance on Third Party Review Program: Process Highlights | FDA Source Cluster: Reg Desk Source Node: 3075260Time Stamp: Jan 18, 2024
SFDA Guidance on Product Classification: Introduction | SFDA Source Cluster: Reg Desk Source Node: 3075262Time Stamp: Jan 18, 2024
FDA Draft Guidance on Real-World Evidence: Specific Aspects | FDA Source Cluster: Reg Desk Source Node: 3078546Time Stamp: Jan 18, 2024
FDA Guidance on Assessing the Credibility of Computational Modeling and Simulation: Special Considerations | FDA Source Cluster: Reg Desk Source Node: 3078548Time Stamp: Jan 18, 2024
NeuroSigma Announces FDA Clearance of its Second-Generation Monarch eTNS System for Treating Pediatric ADHD | BioSpace Source Cluster: BioSpace Source Node: 3068515Time Stamp: Jan 17, 2024